Rocket Pharmaceuticals (RCKT) Other Non Operating Income (2015)
Rocket Pharmaceuticals (RCKT) reported Other Non Operating Income of $38.4 million for Q4 2015, up 182.3% sequentially from -$46.6 million in Q3 2015.
Rocket Pharmaceuticals (RCKT) Other Non Operating Income (2015) Analysis & Trends
Rocket Pharmaceuticals (RCKT) has 1 years of Other Non Operating Income data on file, last reported at $38.4 million in Q4 2015.
- For the quarter ending Q4 2015, Other Non Operating Income changed N/A year-over-year to $38.4 million; the trailing twelve-month figure through Dec 2015 stood at -$7.1 million (changed N/A YoY), and the FY2015 full-year result was -$4.4 million, changed N/A from the prior year.
- Other Non Operating Income grew to $38.4 million in Q4 2015, from -$46.6 million in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of $38.4 million in Q4 2015 to a low of -$46.6 million in Q3 2015.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Rocket Pharmaceuticals | 359.39 Mn | 359.39 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2015 | 38.39 Mn |
| Sep 30, 2015 | -46.65 Mn |
| Jun 30, 2015 | 1.86 Mn |
| Mar 31, 2015 | -683,000.00 |